Transmedics Group Inc (TMDX) Stock Price, Quote & News

Company Profile

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company provides Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of...

Industry: Medical Devices

Sector: Healthcare

Phone: 978 552 0900

Website: www.transmedics.com

Address:

200 Minuteman Road, Suite 302, Andover, United States

Valueforall Sep. 15 at 4:34 PM

$TMDX funny how the market makes you think logic works?

1 · Reply

Valueforall Sep. 15 at 4:25 PM

$TMDX buy low, buy high….all I do is buy buy buy

0 · Reply

Valueforall Sep. 15 at 2:55 PM

$TMDX this equity at this price Buy dips, rips and lulls

0 · Reply

TriGuy8542 Sep. 14 at 11:59 PM

$TMDX insider buy from Dr. Weill!! He’s been two for two in the past before BIG pushes forward in price.

1 · Reply

TriGuy8542 Sep. 14 at 6:29 PM

$TMDX market aggressively exiting AI trade into oversold areas. Let’s see if it lasts.

0 · Reply

Valueforall Sep. 14 at 5:23 PM

$TMDX usually don’t post on Green Day’s but forgive me. it’s a tough business out there and I ain’t gonna sugar coat it. You are either buying dips or sucking 🍆 s. There is no in between when it comes to this algo world of trading. So you gotta get up and look yourself in the mirror. Am I a dip buyer 💪? Or a 🍆 sucker? And then face your wife , kids family and friends with the answer

1 · Reply

TriGuy8542 Sep. 13 at 11:05 PM

$TMDX I’ve decided until CHOPS is approved this is dead in the water. The uptick in logistics activity was driven by a current customer moving to TMDX transportation network, not new share gain.

1 · Reply

SodApOp_PIMPski_Rises Sep. 12 at 1:47 PM

$TMDX clearly failed to continue momentum, not great action but still maintaining the 100dma as support while the 50dma is curling up

0 · Reply

Valueforall Sep. 11 at 4:17 PM

$TMDX buying the dip on this huge today!

0 · Reply

Olddrache Sep. 11 at 2:42 PM

$TMDX Until oil comes back down, dont see this moving anywhere except down or chopping unfortunately.

1 · Reply

TransMedics Group Transcript: 2026 Global Healthcare Conference

Sep 15, 2026, 9:40 AM EDT - 12 hours ago

TransMedics Group Slides: FY 2026

Sep 14, 2026, 3:20 PM EDT - 1 day ago

TransMedics Group Transcript: Morgan Stanley 24th Annual Global Healthcare Conference

Sep 14, 2026, 2:39 PM EDT - 1 day ago

TransMedics Group Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of TransMedics Group, Inc. - TMDX

Sep 10, 2026, 4:05 PM EDT - 5 days ago

TransMedics Appoints Fernando Araujo as Chief Financial Officer and Reiterates 2026 Financial Outlook

Sep 7, 2026, 3:03 PM EDT - 8 days ago

Did TransMedics Group, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Aug 31, 2026, 4:05 PM EDT - 15 days ago

TransMedics to Present at Upcoming September Investor Conferences

Aug 11, 2026, 2:00 PM EDT - 5 weeks ago

TransMedics Group Transcript: Canaccord Genuity's 46th Annual Growth Conference

Aug 11, 2026, 2:00 PM EDT - 5 weeks ago

TransMedics Group Slides: Canaccord Genuity's 46th Annual Growth Conference

Aug 4, 2026, 4:30 PM EDT - 6 weeks ago

TransMedics Group Earnings Call Transcript: Q2 2026

Aug 4, 2026, 4:30 PM EDT - 6 weeks ago

TransMedics Group Earnings release: Q2 2026

Aug 4, 2026, 4:30 PM EDT - 6 weeks ago

TransMedics Group Quarterly report: Q2 2026

Aug 4, 2026, 4:30 PM EDT - 6 weeks ago

TransMedics Group Slides: Q2 2026

Aug 4, 2026, 4:05 PM EDT - 6 weeks ago

TransMedics Reports Second Quarter 2026 Financial Results

Aug 3, 2026, 4:05 PM EDT - 6 weeks ago

TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Jul 28, 2026, 4:29 PM EDT - 7 weeks ago

TransMedics to Present at the Canaccord Genuity 46th Annual Growth Conference

Jul 21, 2026, 4:05 PM EDT - 1 month ago

TransMedics to Report Second Quarter 2026 Financial Results on August 4, 2026

Jul 6, 2026, 7:05 AM EDT - 2 months ago

TransMedics Group Announces Completion of Strategic Investment in PAD Aviation service GmbH

Jun 12, 2026, 8:51 AM EDT - 3 months ago

Johnson Fistel Investigates TransMedics Group, Inc. (TMDX) After Recent Disclosures Concerning Margin Pressure and NOP Investments

Jun 2, 2026, 2:20 PM EDT - 3 months ago

TransMedics Group Transcript: 46th Annual William Blair Growth Stock Conference

Jun 2, 2026, 2:20 PM EDT - 3 months ago

TransMedics Group Slides: 46th Annual William Blair Growth Stock Conference

May 19, 2026, 4:05 PM EDT - 3 months ago

TransMedics to Present at the William Blair 46th Annual Growth Stock Conference

May 7, 2026, 8:00 AM EDT - 4 months ago

TransMedics Group Proxy statement: Proxy filing

May 5, 2026, 4:30 PM EDT - 4 months ago

TransMedics Group Earnings Call Transcript: Q1 2026

May 5, 2026, 4:30 PM EDT - 4 months ago

TransMedics Group Earnings release: Q1 2026

May 5, 2026, 4:30 PM EDT - 4 months ago

TransMedics Group Quarterly report: Q1 2026

May 5, 2026, 4:30 PM EDT - 4 months ago

TransMedics Group Slides: Q1 2026

May 5, 2026, 4:05 PM EDT - 4 months ago

TransMedics Reports First Quarter 2026 Financial Results

Apr 29, 2026, 9:26 AM EDT - 4 months ago

TransMedics Group Announces Intent to Create the First Dedicated European Transplant Logistics Network with Strategic Investment in PAD Aviation service GmbH

Apr 23, 2026, 7:00 AM EDT - 4 months ago

TransMedics to Provide Update on Ongoing Clinical Programs at the International Society of Heart and Lung Transplantation 2026 Annual Meeting

Apr 21, 2026, 4:05 PM EDT - 4 months ago

TransMedics to Report First Quarter 2026 Financial Results on May 5, 2026

Apr 10, 2026, 8:00 AM EDT - 5 months ago

TransMedics Group Proxy statement: Proxy filing

Apr 10, 2026, 8:00 AM EDT - 5 months ago

TransMedics Group Proxy statement: Proxy filing

Mar 16, 2026, 10:00 AM EDT - 6 months ago

TransMedics Group Transcript: Oppenheimer 36th Annual Healthcare MedTech & Services Conference

Mar 2, 2026, 1:50 PM EST - 6 months ago

TransMedics Group Transcript: TD Cowen 46th Annual Health Care Conference

Feb 27, 2026, 7:00 AM EST - 6 months ago

TransMedics Provides Additional Information on the Impact of the Release of the Valuation Allowance on Deferred Tax Assets on Previously Reported Fourth Quarter Financial Results

Feb 24, 2026, 4:30 PM EST - 6 months ago

TransMedics Group Earnings Call Transcript: Q4 2025

Feb 24, 2026, 4:30 PM EST - 6 months ago

TransMedics Group Annual report: Q4 2025

Feb 24, 2026, 4:30 PM EST - 6 months ago

TransMedics Group Earnings release: Q4 2025

Feb 24, 2026, 4:30 PM EST - 6 months ago

TransMedics Group Slides: Q4 2025

Feb 24, 2026, 4:05 PM EST - 6 months ago

TransMedics Reports Fourth Quarter and Full Year 2025 Financial Results

Feb 17, 2026, 4:05 PM EST - 7 months ago

TransMedics to Present at Upcoming March Investor Conferences

Feb 10, 2026, 4:05 PM EST - 7 months ago

TransMedics to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026

Feb 9, 2026, 8:00 AM EST - 7 months ago

TransMedics Receives Full and Unconditional FDA IDE Approval for Next-Generation OCS Heart ENHANCE Trial

Jan 15, 2026, 10:31 AM EST - 8 months ago

These under-the-radar stocks combine fast growth with big upside potential

AGYS ASTH BBT CORT CTRE DCOM DOCN

Jan 12, 2026, 6:00 PM EST - 8 months ago

TransMedics Group Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 12, 2026, 6:00 PM EST - 8 months ago

TransMedics Group Slides: 44th Annual J.P. Morgan Healthcare Conference

Jan 12, 2026, 8:10 AM EST - 8 months ago

TransMedics Announces New Global Headquarters and Expansion at Assembly Innovation Park in Somerville, Massachusetts

Dec 30, 2025, 4:05 PM EST - 8 months ago

TransMedics to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Dec 2, 2025, 9:30 AM EST - 9 months ago

TransMedics Group Transcript: Piper Sandler 37th Annual Healthcare Conference

Nov 18, 2025, 4:05 PM EST - 10 months ago

TransMedics to Participate in the Piper Sandler 37th Annual Healthcare Conference

Oct 29, 2025, 4:30 PM EDT - 10 months ago

TransMedics Group Earnings Call Transcript: Q3 2025

Oct 29, 2025, 4:30 PM EDT - 10 months ago

TransMedics Group Quarterly report: Q3 2025

Oct 29, 2025, 4:30 PM EDT - 10 months ago

TransMedics Group Earnings release: Q3 2025

Oct 29, 2025, 4:30 PM EDT - 10 months ago

TransMedics Group Slides: Q3 2025

Oct 29, 2025, 4:05 PM EDT - 10 months ago

TransMedics Reports Third Quarter 2025 Financial Results

Oct 15, 2025, 4:05 PM EDT - 11 months ago

TransMedics to Report Third Quarter 2025 Financial Results on October 29, 2025

Sep 22, 2025, 2:00 AM EDT - 11 months ago

TransMedics and Mercedes-Benz Announce Strategic Collaboration to Launch First Dedicated Organ Transplantation Ground Transportation Network in Italy

Sep 9, 2025, 12:15 PM EDT - 1 year ago

TransMedics Group Transcript: Baird Global Healthcare Conference 2025

Sep 8, 2025, 10:00 AM EDT - 1 year ago

TransMedics Group Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference

Aug 12, 2025, 8:00 PM EDT - 1 year ago

Technical Tuesday: SPX All-Time High, OKLO Bull Flags & TMDX Bullish SMA

OKLO

Aug 12, 2025, 11:30 AM EDT - 1 year ago

TransMedics Group Transcript: Canaccord Genuity’s 45th Annual Growth Conference

Aug 4, 2025, 8:00 AM EDT - 1 year ago

TransMedics Receives FDA IDE Approval to Initiate Next-Generation OCS Heart Trial

Jul 30, 2025, 4:30 PM EDT - 1 year ago

TransMedics Group Earnings Call Transcript: Q2 2025

Jul 30, 2025, 4:30 PM EDT - 1 year ago

TransMedics Group Quarterly report: Q2 2025

Jul 30, 2025, 4:30 PM EDT - 1 year ago

TransMedics Group Earnings release: Q2 2025

Jul 30, 2025, 4:30 PM EDT - 1 year ago

TransMedics Group Slides: Q2 2025

Jul 30, 2025, 4:05 PM EDT - 1 year ago

TransMedics Reports Second Quarter 2025 Financial Results

Jul 29, 2025, 4:05 PM EDT - 1 year ago

TransMedics to Present at the Canaccord Genuity 45th Annual Growth Conference

Jul 23, 2025, 4:17 PM EDT - 1 year ago

This Company Transports Donated Organs. Its Stock Has Had a Roller-Coaster Ride.

Jul 16, 2025, 4:05 PM EDT - 1 year ago

TransMedics to Report Second Quarter 2025 Financial Results on July 30, 2025

Jun 9, 2025, 8:00 AM EDT - 1 year ago

TransMedics Group Transcript: Goldman Sachs 46th Annual Global Healthcare Conference

Jun 3, 2025, 5:00 PM EDT - 1 year ago

TransMedics Group Transcript: 45th Annual William Blair Growth Stock Conference

May 20, 2025, 4:05 PM EDT - 1 year ago

TransMedics to Present at Upcoming June Investor Conferences

Valueforall Sep. 15 at 4:34 PM

$TMDX funny how the market makes you think logic works?

1 · Reply

Valueforall Sep. 15 at 4:25 PM

$TMDX buy low, buy high….all I do is buy buy buy

0 · Reply

Valueforall Sep. 15 at 2:55 PM

$TMDX this equity at this price Buy dips, rips and lulls

0 · Reply

TriGuy8542 Sep. 14 at 11:59 PM

$TMDX insider buy from Dr. Weill!! He’s been two for two in the past before BIG pushes forward in price.

1 · Reply

TriGuy8542 Sep. 14 at 6:29 PM

$TMDX market aggressively exiting AI trade into oversold areas. Let’s see if it lasts.

0 · Reply

Valueforall Sep. 14 at 5:23 PM

1 · Reply

TriGuy8542 Sep. 13 at 11:05 PM

$TMDX I’ve decided until CHOPS is approved this is dead in the water. The uptick in logistics activity was driven by a current customer moving to TMDX transportation network, not new share gain.

1 · Reply

SodApOp_PIMPski_Rises Sep. 12 at 1:47 PM

$TMDX clearly failed to continue momentum, not great action but still maintaining the 100dma as support while the 50dma is curling up

0 · Reply

Valueforall Sep. 11 at 4:17 PM

$TMDX buying the dip on this huge today!

0 · Reply

Olddrache Sep. 11 at 2:42 PM

$TMDX Until oil comes back down, dont see this moving anywhere except down or chopping unfortunately.

1 · Reply

theenlightenedone1010 Sep. 11 at 2:41 PM

$TMDX beautiful downside move bulls have ignored the signs the whole time, and fully deserve to lose every single dollar invested in this

1 · Reply

alnaqbi Sep. 11 at 2:40 PM

$TMDX added a bit more

0 · Reply

Lambster2 Sep. 10 at 9:26 PM

$TMDX TransMedics (NASDAQ: TMDX) Buy (1) Price Target: $120.00 New CFO Has Extensive Public-Co Experience and Can Help Drive Growth Inflection THE TD COWEN INSIGHT TMDX has named Fernando Araujo its new CFO, replacing Gerardo Hernandez, who will now lead TMDX's expansion into LatAm. Mr. Araujo was most recently CFO of GEHC's Advanced Imaging Solutions segment and has over two decades of public company experience. We think he is a strong choice to help drive TMDX's planned growth inflection, which will require rapid scaling and a focus on operating leverage.

0 · Reply

roblake29 Sep. 9 at 8:35 PM

$TMDX My latest write-up. I am maintaining my hold rating. Lots to like, but lots to question. If you know better, please tell me. https://seekingalpha.com/article/4943749-transmedics-slowing-growth-brings-its-valuation-into-question

1 · Reply

Twister8 Sep. 9 at 2:45 PM

$TMDX 80-85 range, dead money until news.

0 · Reply

Lambster2 Sep. 8 at 2:18 PM

$TMDX Added 87.59

0 · Reply

Lambster2 Sep. 8 at 12:14 PM

$TMDX TransMedics (NASDAQ: TMDX) Buy (1) Price Target: $120.00 HQ Visit Recap: Multiple Growth Engines Are Converging Into 2027, Reiterate Buy THE TD COWEN INSIGHT Our HQ visit made us increasingly bullish on the 2H’26/2027 setup. 3Q trends are benefiting from transplant-volume recovery and continued liver share gains. A 2027 reacceleration could come into play as ENHANCE Part B, DENOVO, CHOPS, OCS kidney and Italy/OUS expansion begin layering on top of the core OCS/NOP/Aviation offering, driving stronger revenue growth and operating leverage. Reiterate Buy.

0 · Reply

JFais Sep. 8 at 12:21 AM

$TMDX - good example of Playbook idea that ran away from desired entry point, quick rebound from $70 to $90 https://x.com/jfais20/status/2085001342674706625/photo/1

0 · Reply

CapitalMonk Sep. 5 at 12:02 AM

$TMDX Price: $86.98 (+3.19%) Trend: Bearish Market Bias (7D): Bullish Bias 📈 Expected Range: ±1.06% RSI: 47.3 | Momentum: Moderate Volume: -17.7% vs avg Volatility: 3.02% Support: $79.51 | Resistance: $95.18 Data and analytics sourced from Thescanner educational research https://www.thescanner.ai

0 · Reply

SodApOp_PIMPski_Rises Sep. 4 at 11:12 PM

$TMDX if momentum can continue next week a close over 95 will bring a test of the 200dma at 105

0 · Reply

Valueforall Sep. 4 at 7:43 PM

$TMDX buy this dip, buy this rip! Everyone needs to buy this 💩!!!

0 · Reply

CapitalMonk Sep. 3 at 11:01 PM

$TMDX Price: $86.98 (+3.19%) Trend: Bearish Market Bias (7D): Bullish Bias 📈 Expected Range: ±1.01% RSI: 47.3 | Momentum: Moderate Volume: -17.7% vs avg Volatility: 3.02% Support: $79.51 | Resistance: $95.18 Data and analytics sourced from Thescanner educational research https://www.thescanner.ai

0 · Reply

Market Cap	2.97B
Revenue (ttm)	605.49M
Net Income (ttm)	190.29M
EPS (ttm)	N/A
PE Ratio	41.72
Forward PE	56.48
Profit Margin	31.43%
Debt to Equity Ratio	0.12

Volume	942,800
Avg Vol	837,720
Day's Range	N/A - N/A
Shares Out	34.56M
Stochastic %K	77%
Beta	1.90
Analysts	Sell
Price Target	$94.82